🇺🇸 FDA
Patent

US 7189741

Indolylpiperidine derivatives as antihistaminic and antiallergic agents

granted A61PA61P11/00A61P11/02

Quick answer

US patent 7189741 (Indolylpiperidine derivatives as antihistaminic and antiallergic agents) held by Almirall Prodesfarma S.A. expires Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall Prodesfarma S.A.
Grant date
Tue Mar 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P11/00, A61P11/02, A61P11/06, A61P11/08